Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TRPM7 regulates gastrulation during vertebrate embryogenesis.
Liu W, Su LT, Khadka DK, Mezzacappa C, Komiya Y, Sato A, Habas R, Runnels LW. Liu W, et al. Among authors: sato a. Dev Biol. 2011 Feb 15;350(2):348-57. doi: 10.1016/j.ydbio.2010.11.034. Epub 2010 Dec 9. Dev Biol. 2011. PMID: 21145885 Free PMC article.
Mechanism of activation of the Formin protein Daam1.
Liu W, Sato A, Khadka D, Bharti R, Diaz H, Runnels LW, Habas R. Liu W, et al. Among authors: sato a. Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):210-5. doi: 10.1073/pnas.0707277105. Epub 2007 Dec 27. Proc Natl Acad Sci U S A. 2008. PMID: 18162551 Free PMC article.
HBV-KMT2B integration drives hepatic oncogenic processes in a human gene-edited iPSC-derived model.
Tsuchiya J, Miyoshi M, Kakinuma S, Kawai-Kitahata F, Kamiya A, Shimizu T, Sato A, Watakabe K, Mochida T, Inada K, Kamimae R, Kaneko S, Murakawa M, Nitta S, Nakagawa M, Watanabe M, Asahina Y, Okamoto R. Tsuchiya J, et al. Among authors: sato a. Cell Mol Gastroenterol Hepatol. 2024 Oct 15:101422. doi: 10.1016/j.jcmgh.2024.101422. Online ahead of print. Cell Mol Gastroenterol Hepatol. 2024. PMID: 39419394 Free article.
Impact of extended endocrine therapy for patients with risk factors for late recurrence in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after 5 years of endocrine therapy.
Ito M, Amari M, Sato A, Hikichi M, Tsurumi N, Otofuji H, Saji S. Ito M, et al. Among authors: sato a. Breast Cancer Res Treat. 2024 Oct 17. doi: 10.1007/s10549-024-07509-1. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39417907
5,404 results